Effectiveness of rituximab as prophylaxis in thrombotic thrombocytopenic purpura

dc.contributor.authorBenetatos, L.en
dc.contributor.authorVassou, A.en
dc.contributor.authorBourantas, K. L.en
dc.date.accessioned2015-11-24T19:21:58Z
dc.date.available2015-11-24T19:21:58Z
dc.identifier.issn0141-9854-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22135
dc.rightsDefault Licence-
dc.subjectAntibodies, Monoclonal/*administration & dosageen
dc.subjectAntibodies, Monoclonal, Murine-Deriveden
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectImmunologic Factors/*administration & dosageen
dc.subjectPurpura, Thrombotic Thrombocytopenic/*drug therapyen
dc.titleEffectiveness of rituximab as prophylaxis in thrombotic thrombocytopenic purpuraen
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1111/j.1365-2257.2006.00794.x-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/16898975-
heal.journalNameClin Lab Haematolen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2006-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: